GPX4 and colorectal carcinoma: In addition, Kaplan–Meier analysis exhibited that CRC patients who had positive co-expression of either LINC00239/Nrf2 or LINC00239/GPX4 showed the lowest survival times in both CRC cohorts (Fig. 7D, E, I–J).